Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,87 USD | +1,08% | -9,66% | +32,62% |
Omzet 2024 * | 250K 235K | Omzet 2025 * | 250K 235K | Marktkapitalisatie | 313 mln. 294 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -133 mln. -125 mln. | Nettowinst (verlies) 2025 * | -151 mln. -142 mln. | EV/omzet 2024 * | 1.025 x |
Nettoliquiditeiten 2024 * | 56,8 mln. 53,37 mln. | Nettoliquiditeiten 2025 * | 168 mln. 158 mln. | EV/omzet 2025 * | 579 x |
K/w-verhouding 2024 * |
-2,41
x | K/w-verhouding 2025 * |
-2,43
x | Werknemers | 83 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 90,01% |
Recentste transcriptie over Atai Life Sciences N.V.
1 dag | +1,08% | ||
1 week | -9,66% | ||
Lopende maand | -5,08% | ||
1 maand | +14,72% | ||
3 maanden | +2,75% | ||
6 maanden | +43,85% | ||
Lopend jaar | +32,62% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Florian Brand
CEO | Chief Executive Officer | 37 | 01-06-18 |
Srinivas Rao
FOU | Founder | 55 | 01-06-18 |
Anne Johnson
DFI | Director of Finance/CFO | - | 01-01-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Sabrina Johnson
BRD | Director/Board Member | 57 | 01-01-21 |
Founder | 46 | 01-06-18 | |
Amir Kalali
BRD | Director/Board Member | 58 | - |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.84% | 1 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
22-04-24 | 1,87 | +1,08% | 1 049 274 |
19-04-24 | 1,85 | -3,14% | 1 004 850 |
18-04-24 | 1,91 | -3,54% | 1 016 792 |
17-04-24 | 1,98 | -7,91% | 1 473 352 |
16-04-24 | 2,15 | +3,86% | 1 211 619 |
uitgestelde koers Nasdaq, 22 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+32,62% | 313 mln. | |
-0,02% | 42,11 mld. | |
+44,76% | 40,08 mld. | |
+5,04% | 40 mld. | |
-11,32% | 26,87 mld. | |
+5,25% | 24,58 mld. | |
-23,83% | 18,44 mld. | |
-1,62% | 11,94 mld. | |
+22,75% | 11,66 mld. | |
+6,44% | 11,01 mld. |